Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.

Li-Hua QuQian FangTong YinHui-Mei YiGuang-Bo MeiZi-Zhan HongXue-Bing QiuRui ZhouHui-Fen Dong

Published in: Cancer immunology, immunotherapy : CII (2022)

Overall, our current results indicated that KDM1A/1B/3A/4A/5B/5C and KDM6A could be novel prognostic biomarkers and provide insights into potential immunotherapy targets to HCC patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
dna methylation
peritoneal dialysis
risk assessment
climate change